Hyperlipidemia

被引：39
作者：
Eaton, CB
机构：
[1] Brown Univ, Mem Hosp Rhode Isl, Pawtucket, RI 02860 USA
[2] Brown Med Sch, Providence, RI 02912 USA
来源：
PRIMARY CARE | 2005年 / 32卷 / 04期
关键词：
D O I：
10.1016/j.pop.2005.09.002
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Over the past 20 years, a link between lipoprotein disorders and atherosclerosis, and its clinical manifestations of myocardial infarction, stroke, and sudden cardiac death, has been conclusively demonstrated. This article reviews lipoprotein metabolism, its pathophysiology, describes an approach for the management of patients with lipid disorders and discusses therapy using the ATP III guidelines.
引用
收藏
页码：1027 / +
页数：30
相关论文
共 33 条
[1]   Task force 1: The ACCF and AHA codes of conduct in human subjects research [J].
Adams, RJ ;
Antman, EM ;
Kavey, REW .
CIRCULATION, 2004, 110 (16) :2512-2516
[2]   High-density lipoprotein cholesterol in the cardiovascular equation: Does the "Good" still count? [J].
Alsheikh-Ali, AA ;
Kuvin, JT ;
Karas, RH .
ATHEROSCLEROSIS, 2005, 180 (02) :217-223
[3]  
[Anonymous], LONG DIST CAR GIV 2Q
[4]   Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia [J].
Athyros, VG ;
Papageorgiou, AA ;
Hatzikonstandinou, HA ;
Didangelos, TP ;
Carina, MV ;
Kranitsas, DF ;
Kontopoulos, AG .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (05) :608-613
[5]   Increasing HDL cholesterol levels [J].
Brewer, HB .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1491-1494
[6]   Comparison of current guidelines for primary prevention of coronary heart disease - Risk assessment and lipid-lowering therapy [J].
Broedl, UC ;
Geiss, HC ;
Parhofer, KG .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 (03) :190-195
[7]   Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol [J].
Brousseau, ME ;
Schaefer, EJ ;
Wolfe, ML ;
Bloedon, LT ;
Digenio, AG ;
Clark, RW ;
Mancuso, JP ;
Rader, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1505-1515
[8]   Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease [J].
Brown, BG ;
Zhao, XQ ;
Chait, A ;
Fisher, LD ;
Cheung, MC ;
Morse, JS ;
Dowdy, AA ;
Marino, EK ;
Bolson, EL ;
Alaupovic, P ;
Frohlich, J ;
Albers, JJ ;
Serafini, L ;
Huss-Frechette, E ;
Wang, S ;
DeAngelis, D ;
Dodek, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1583-1592
[9]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[10]  
Collins R, 2003, LANCET, V361, P2005
1234